ROCHE Finance Ltd., 10% Owner at Pandion Therapeutics, Inc. (PAND), bought 3,086,084 shares at $18.00 ($650K) on 2020-07-21, disclosed to the SEC on 2020-07-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,049,973 | $0 | 0.0% |
| 2 | $18.00 | 36,111 | $650K | 100.0% |
| Total | $0.21 avg | 3,086,084 | $650K | 100% |